Results 141 to 150 of about 28,687 (180)

Capsular Polysaccharides of Cryptococcus neoformans

Clinical Infectious Diseases, 1984
Polysaccharides of Cryptococcus neoformans are considered to have a role in the virulence of this encapsulated fungus. The structure has been determined for the most abundant polysaccharide, a glucuronoxylomannan of varying xylose and ester content. The structural complexity of the capsular material increases from serotype D to A to B to C, but even ...
A K, Bhattacharjee, J E, Bennett, C P, Glaudemans   +2 more
openaire   +2 more sources

Phospholipase activity in Cryptococcus neoformans

Mycopathologia, 1996
Phospholipases have only been detected in a few fungi and yeasts, in particular in Candida albicans. Secreted phospholipases are considered by some researchers to be a potential factor of virulence and pathogenicity in C. albicans. Twenty-three Cryptococcus neoformans strains were tested in order to observe phospholipase production.
V, Vidotto, A, Sinicco, D, Di Fraia, S, Cardaropoli, S, Aoki, S, Ito-Kuwa   +5 more
openaire   +2 more sources

Drug resistance in Cryptococcus neoformans

Drug Resistance Updates, 1999
Cryptococcus neoformans has become a major opportunistic fungal pathogen worldwide. Successful treatment of invasive disease with this fungus has used amphotericin B, flucytosine and various azoles. However, treatment failures continue to occur for a variety of reasons including direct antifungal drug resistance.
John R., Perfect, Gary M., Cox
openaire   +2 more sources

Cryptococcus neoformans

2012
Cryptococcosis is caused by 2 varieties of Cryptococcus neoformans: Cryptococcus neoformans var neoformans (serotypes A and D) and Cryptococcus neoformans var gatti (serotypes B and C). Serotypes A and D are found worldwide, mostly in avian droppings. Serotypes B and C are found in tropical and subtropical countries in association with eucalyptus trees.
Shimon Kusne, Ann E McCullough
openaire   +1 more source

The commensalism ofCryptococcus neoformans

Medical Mycology, 1973
Cryptococcus neoformans, was isolated from 3 of 561 sputum specimens. The fungus was not recovered from 162 samples of saliva or 310 fecal specimens. These data document the rarity of isolation of C. neoformans from human material but establish that it may be a commensal of the human nasopharynx under circumstances.
openaire   +2 more sources

ISOLATION OF CRYPTOCOCCUS NEOFORMANS

The Lancet, 1982
D R, McCluskey, J P, Evans, D W, Mackenzie   +2 more
openaire   +2 more sources

MSG07: An International Cohort Study Comparing Epidemiology and Outcomes of Patients With Cryptococcus neoformans or Cryptococcus gattii Infections

Clinical Infectious Diseases, 2021
John W Baddley, Sharon C-A Chen, Carrie Huisingh   +2 more
exaly  

Cryptococcus neoformans

Canadian journal of medical technology, 1998
Arturo Casadevall, John R. Perfect
openaire   +3 more sources

Cryptococcus neoformans and Cryptococcosis

Journal of Infection, 2000
openaire   +2 more sources

Cryptococcus Species Other Than Cryptococcus neoformans and Cryptococcus gattii: Are They Clinically Significant?

Open Forum Infectious Diseases, 2020
Edison J Cano, Zachary A Yetmar, Raymund R Razonable   +2 more
exaly